Literature DB >> 17846870

Recrystallization of nifedipine and felodipine from amorphous molecular level solid dispersions containing poly(vinylpyrrolidone) and sorbed water.

Patrick J Marsac1, Hajime Konno, Alfred C F Rumondor, Lynne S Taylor.   

Abstract

PURPOSE: To compare the physical stability of amorphous molecular level solid dispersions of nifedipine and felodipine, in the presence of poly(vinylpyrrolidone) (PVP) and small amounts of moisture.
METHODS: Thin amorphous films of nifedipine and felodipine and amorphous molecular level solid dispersions with PVP were stored at various relative humidities (RH) and the nucleation rate was measured. The amount of water sorbed at each RH was measured using isothermal vapor sorption and glass transition temperatures (Tg) were determined using differential scanning calorimetry. The solubility of each compound in methyl pyrrolidone was measured as a function of water content.
RESULTS: Nifedipine crystallizes more easily than felodipine at any given polymer concentration and in the presence of moisture. The glass transition temperatures of each compound, alone and in the presence of PVP, are statistically equivalent at any given water content. The nifedipine systems are significantly more hygroscopic than the corresponding felodipine systems.
CONCLUSIONS: Variations in the physical stability of the two compounds could not be explained by differences in Tg. However, the relative physical stability is consistent with differences in the degree of supersaturation of each drug in the solid dispersion, treating the polymer and water as a co-solvent system for each drug compound.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17846870     DOI: 10.1007/s11095-007-9420-3

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  31 in total

Review 1.  Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes.

Authors:  K R Morris; U J Griesser; C J Eckhardt; J G Stowell
Journal:  Adv Drug Deliv Rev       Date:  2001-05-16       Impact factor: 15.470

2.  Explanation of the crystallization rate of amorphous nifedipine and phenobarbital from their molecular mobility as measured by (13)C nuclear magnetic resonance relaxation time and the relaxation time obtained from the heating rate dependence of the glass transition temperature.

Authors:  Y Aso; S Yoshioka; S Kojima
Journal:  J Pharm Sci       Date:  2001-06       Impact factor: 3.534

3.  Enthalpy relaxation in binary amorphous mixtures containing sucrose.

Authors:  S L Shamblin; G Zografi
Journal:  Pharm Res       Date:  1998-12       Impact factor: 4.200

4.  Moisture-dependent crystallization of amorphous lamotrigine mesylate.

Authors:  E Schmitt; C W Davis; S T Long
Journal:  J Pharm Sci       Date:  1996-11       Impact factor: 3.534

5.  Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization.

Authors:  T Matsumoto; G Zografi
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

6.  A comparison of the physical stability of amorphous felodipine and nifedipine systems.

Authors:  Patrick J Marsac; Hajime Konno; Lynne S Taylor
Journal:  Pharm Res       Date:  2006-08-23       Impact factor: 4.200

7.  Properties of solid dispersions of piroxicam in polyvinylpyrrolidone.

Authors:  V Tantishaiyakul; N Kaewnopparat; S Ingkatawornwong
Journal:  Int J Pharm       Date:  1999-04-30       Impact factor: 5.875

8.  Ability of polyvinylpyrrolidone and polyacrylic acid to inhibit the crystallization of amorphous acetaminophen.

Authors:  Tamaki Miyazaki; Sumie Yoshioka; Yukio Aso; Shigeo Kojima
Journal:  J Pharm Sci       Date:  2004-11       Impact factor: 3.534

9.  Inhibition of indomethacin crystallization in poly(vinylpyrrolidone) coprecipitates.

Authors:  M Yoshioka; B C Hancock; G Zografi
Journal:  J Pharm Sci       Date:  1995-08       Impact factor: 3.534

10.  The relationship between the glass transition temperature and water vapor absorption by poly(vinylpyrrolidone)

Authors:  C A Oksanen; G Zografi
Journal:  Pharm Res       Date:  1990-06       Impact factor: 4.200

View more
  15 in total

Review 1.  Impact of excipient interactions on drug bioavailability from solid dosage forms.

Authors:  Ravikiran Panakanti; Ajit S Narang
Journal:  Pharm Res       Date:  2012-05-19       Impact factor: 4.200

2.  Understanding the tendency of amorphous solid dispersions to undergo amorphous-amorphous phase separation in the presence of absorbed moisture.

Authors:  Alfred C F Rumondor; Håkan Wikström; Bernard Van Eerdenbrugh; Lynne S Taylor
Journal:  AAPS PharmSciTech       Date:  2011-09-17       Impact factor: 3.246

3.  Understanding the behavior of amorphous pharmaceutical systems during dissolution.

Authors:  David E Alonzo; Geoff G Z Zhang; Deliang Zhou; Yi Gao; Lynne S Taylor
Journal:  Pharm Res       Date:  2010-02-12       Impact factor: 4.200

4.  The Physical Stability of Felodipine and Its Recrystallization from an Amorphous Solid Dispersion Studied by NMR Relaxometry.

Authors:  A Pajzderska; J Mielcarek; J Wąsicki
Journal:  AAPS PharmSciTech       Date:  2022-03-21       Impact factor: 3.246

5.  Evaluation of drug-polymer miscibility in amorphous solid dispersion systems.

Authors:  Alfred C F Rumondor; Igor Ivanisevic; Simon Bates; David E Alonzo; Lynne S Taylor
Journal:  Pharm Res       Date:  2009-09-22       Impact factor: 4.200

6.  Effects of polymer type and storage relative humidity on the kinetics of felodipine crystallization from amorphous solid dispersions.

Authors:  Alfred C F Rumondor; Lindsay A Stanford; Lynne S Taylor
Journal:  Pharm Res       Date:  2009-10-06       Impact factor: 4.200

7.  The effects of polymer carrier, hot melt extrusion process and downstream processing parameters on the moisture sorption properties of amorphous solid dispersions.

Authors:  Xin Feng; Anh Vo; Hemlata Patil; Roshan V Tiwari; Abdullah S Alshetaili; Manjeet B Pimparade; Michael A Repka
Journal:  J Pharm Pharmacol       Date:  2015-11-21       Impact factor: 3.765

8.  A novel drug-drug coamorphous system without molecular interactions: improve the physicochemical properties of tadalafil and repaglinide.

Authors:  Meiling Su; Yanming Xia; Yajing Shen; Weili Heng; Yuanfeng Wei; Linghe Zhang; Yuan Gao; Jianjun Zhang; Shuai Qian
Journal:  RSC Adv       Date:  2020-01-02       Impact factor: 4.036

9.  Physical Properties and Effect in a Battery of Safety Pharmacology Models for Three Structurally Distinct Enteric Polymers Employed as Spray-Dried Dispersion Carriers.

Authors:  Ryan M Fryer; Mita Patel; Xiaomei Zhang; Katja S Baum-Kroker; Akalushi Muthukumarana; Brian Linehan; Yin-Chao Tseng
Journal:  Front Pharmacol       Date:  2016-10-13       Impact factor: 5.810

10.  Fluoroquinolone Amorphous Polymeric Salts and Dispersions for Veterinary Uses.

Authors:  Hanah Mesallati; Anita Umerska; Lidia Tajber
Journal:  Pharmaceutics       Date:  2019-06-09       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.